Search results
IRLAB's Phase IIb Study of Pirepemat Can Proceed as Planned after Positive Opinion from External...
Digital Journal· 2 days agoAbout IRLAB IRLAB discovers and develops a portfolio of transformative treatments for all stages of Parkinson's disease. The company originates from Nobel Laureate Prof Arvid Carlsson ...